US Patent Issued to MOLECULAR SKIN THERAPEUTICS on April 22 for "Benzoxazinone compounds as KLK5/7 dual inhibitors" (California Inventors)

ALEXANDRIA, Va., June 6 -- United States Patent no. 12,281,123, issued on April 22, was assigned to MOLECULAR SKIN THERAPEUTICS INC. (Palo Alto, Calif.).

"Benzoxazinone compounds as KLK5/7 dual inhibitors" was invented by Andreas Betz (Palo Alto, Calif.) and Robert Zamboni (Palo Alto, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides compounds and pharmaceutical compositions including the compounds for the treatment of a skin disease associated with proteolytic activity of one or more KLK proteases, wherein the compounds are according to formula (I):wherein R is as described herein."

The patent was filed on April 3, 2023, under Application No. 18/295,009.

*For further inf...